/Lists

Biotech Investors & VC Firms in North America

1590 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

AlleyCorp
New YorkPre-Seed–Series A$1M – $5M
32 people
TPG
San FranciscoGrowth–Late Stage
75 people
Amplify Partners
Menlo ParkPre-Seed–Series A$500K – $5M
30 people
Pillar VC
BostonPre-Seed–Series A$50K – $4M
60 people
NVIDIA
Santa ClaraPre-Seed–Growth
23 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
57 people
Portfolia
San MateoSeed–Series B
58 people
Cota Capital
San FranciscoPre-Seed–Series C
26 people
Unknown Ventures
AustinPre-Seed–Series A
88 people
Cultivation Capital
St. LouisSeed–Series B$100K – $3.5M
40 people
Big Red Ventures
IthacaPre-Seed–Series A$25K
83 people
Birch Hill Equity Partners Management Inc.
TorontoGrowth–Late Stage$75M – $3B
74 people
Polaris Partners
BostonSeed–Growth$500K – $5M
50 people
Sierra Ventures
San MateoPre-Seed–Series A$500K – $10M
19 people
The E14 Fund
CambridgePre-Seed–Series A$1M – $5M
16 people
Third Rock Ventures
BostonSeed–Series C$100K – $5M
62 people
Flucas Ventures
JupiterSeed–Series A$100K – $5M
1 person
Obvious Ventures
San FranciscoPre-Seed–Late Stage$250K – $6M
37 people
IndieBio
San FranciscoPre-Seed–Seed$525K
81 people
Sky9 Capital
San FranciscoPre-Seed–Growth$1M – $10M
44 people
HOF Capital
New YorkPre-Seed–Growth$500K – $10M
37 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
77 people
Thompson Street Capital Partners
St. LouisGrowth–Late Stage$50M – $500M
62 people
Altas Partners
TorontoGrowth–Late Stage
84 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.